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Middle aged Professors of Dermatology know that hair provides
an excellent sun block. The paper by Nyholt and colleagues, in
passing, mentions they may have more to worry about: pleiotro-
pic genes.
It has been customary for many years for introductory biology
books to use the genetics of human skin and hair color as an ex-
ample of how genes in£uence form. In reality, however much the
apparent genetic imprint on such traits, we have until recently
known precious little about the details. Nyholt and colleagues
point out that there is to date only one extensive family study of
male pattern baldness and so add some important ¢ndings of
their own to our knowledge about the genetics of human scalp
hair biology (aka baldness).
In the 19th and early 20th centuries, variation of skin and hair
provided fertile material for the geneticists who worked with and
followed Francis Galton. Variation in skin color, hair color and
balding were all easily observable traits that could be subject to a
myriad of correlation statistics. For instance, what is now Cold
Spring Harbor Laboratory was home to the Davenports and the
Carnegie Institute, and the pioneering studies on red hair were
conducted there. Time went by, many of these studies were for-
gotten, and only recently have researchers learned that the old
data was not always as substantial as we would like, and that the
methods of analysis as well as the facility of modern genetics has
changed what can be considered experimentally tractable.
Nyholt et al have used modern twin statistical modelling to ex-
amine the hereditability of male pattern baldness (p. 1561). They
point out in passing that such baldness is associated with coronary
heart disease, hypertension, and benign prostatic hypertrophy,
and state that it is the most common reason for making men
self-conscious (their schooling must have di¡ered from mine).
What do they ¢nd and what does it mean?
They report a high hereditability for male pattern baldness
( 80%). That is, that much of the variation in this trait can be
explained in terms of a genetic model in which there is a greater
similarity between identical than non-identical twins, and that in
turn, the additive e¡ects (as contrasted with epistatic or domi-
nance e¡ects) are large. Understanding variation in form is a re-
ward in itselfat least some of us think thisbut the authors
speculate that their work may facilitate identi¢cation of genes
that predict cardiovascular status and other health outcomes.Time
will tell.
Cancer was not always viewed as a genetic disease, and at the
level of the population, this statement, as epidemiology has con-
sistently shown, was always manifestly false: the heritability of
most human cancers is low. It shouldn’t be a surprise therefore to
¢nd that in the past there were other dominant themes for the-
ories of cancer etiology, amongst the most popular, infection and
environmental toxins. Viruses, as we are constantly being re-
minded, haven’t gone away metaphorically or literally.
The paper by Struijk and colleagues (p. 1531) addresses an
issue that those of us who watch from the touchline would love
to see resolved: what exactly is the relation between HPV and
skin cancer? Is it causal or is the virus just along for the ride, a
marker of some other cognate state? And whereas so often im-
provements in technology allow biology’s secrets to make them-
selves plain, in this instance the power and sensitivity of PCR,
and the complications this sensitivity brings, almost makes one
long for days of Southern blotting or just plain electron micro-
scopy.
The authors report an association between some HPV types,
the EV associated types, and a history of squamous cancer of the
skin. Their samples for HPVanalysis were from plucked eyebrow
hairs, and they discuss their ¢ndings in the light of the apparent
immune privileged status of part of the hair follicle.They empha-
size that the association and prevalence is dependent on the broad
type of HPV, with for instance the high-risk mucosal type
HPV17 and the skin wart type HPV2 being uncommon, but that
no particular EV species dominated their association. So, the data
adds to the plot, with some speci¢city, but as yet no clear
answer to the question about whether the virus is causal or a mar-
ker for other processes such as changes in the immune system of
the host.
Finally, for those interested in the history of how clinically
relevant discovery occurs, there are two papers worth £agging
up. First, Mrowietz et al (p. 1383) have studied the mechanism by
which fumarates achieve their impressive clinical e¡ects. In the
age of new biologics and widespread cost containment it seems
bizarre that e¡ective drug treatments widely used in some coun-
tries are not available in others. Second, Birlklein and colleagues
(p. 1312) look at the clinical e¡ects of botulinum type B (rather
than type A). As ever it seems harder to know how to use a drug
than to ¢nd a drug in the ¢rst place.
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